Novartis Scemblix gets USFDA nod for chronic myeloid leukemia Ruchika Sharma31 Oct 2021 10:00 AM ISTBasel: Novartis has recently announced that the US Food and Drug Administration (FDA) has approved Scemblix (asciminib) for the treatment of chronic...
Setback: Novartis lung cancer drug fails phase 3 study CANOPY-1 Ruchika Sharma26 Oct 2021 10:00 AM ISTBasel: Novartis has announced that the CANOPY-1 Phase III study did not demonstrate the statistically significant primary endpoints of overall...
Novartis, BioNTech ink pact to support fill, finish of mRNA Pfizer-BioNTech COVID vaccine Ruchika Sharma22 Oct 2021 2:54 PM ISTBasel: Novartis has announced that the company has signed an initial agreement to leverage its manufacturing capacity and capabilities to address the...
Novartis LNA043 for knee osteoarthritis gets USFDA fast track status Ruchika Sharma5 Sept 2021 10:15 AM ISTLNA043 is a ANGPTL3 agonist that targets damaged cartilage and modulates several pathways involved in cartilage regeneration.
Novartis pediatric psoriasis treatment Cosentyx approved in China Ruchika Sharma18 Aug 2021 3:46 PM ISTBasel: Novartis has recently announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx (secukinumab) for...
Novartis gets CDSCO Committee nod to Xolair to treat rhinosinusitis with nasal polyps Medical Dialogues Team17 March 2021 9:15 AM ISTNew Delhi: Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization (CDSCO) has granted permission to Novartis...
Novartis India reports net loss at Rs 71 lakh in Q3 Ruchika Sharma14 Feb 2021 9:00 AM ISTNew Delhi: Drug firm Novartis India on Thursday reported a net loss of Rs 71 lakh for the quarter ended December 31, 2020.The company had posted...
Novartis gets USFDA Breakthrough Therapy designations for STAMP inhibitor asciminib to treat chronic myeloid leukemia Ruchika Sharma9 Feb 2021 11:00 AM ISTAsciminib (ABL001) is an investigational treatment specifically targeting the ABL myristoyl pocket (STAMP).
Novartis to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine production Ruchika Sharma1 Feb 2021 12:33 PM ISTBasel: Pharma major, Novartis, has recently announced that the company has signed an initial agreement to leverage its manufacturing capacity and...
Covid-19: Novartis in discussion with firms for manufacturing vaccines, tests Ruchika Sharma30 Jan 2021 9:00 AM ISTZurich: Novartis is talking to other companies about helping to make vaccines and tests for COVID-19, the Swiss drugmaker said on Thursday without...
Novartis Committed to Sandoz generic business: CEO Vas Narasimhan Ruchika Sharma27 Jan 2021 12:37 PM ISTZurich: Novartis Chief Executive Vas Narasimhan on Tuesday renewed his commitment to his Sandoz generic unit where sales growth in 2020 stagnated due...
Novartis inclisiran gets complete USFDA response letter for treating hyperlipidemia Ruchika Sharma21 Dec 2020 1:01 PM ISTThe FDA stated that the agency cannot approve the NDA by the Prescription Drug User Fee Act(PDUFA) action date of December 23, 2020, due to unresolved...
